Centrum Broking Ltd ("Manager to the Buyback") has submitted to BSE a copy of Post Buyback Public Announcement for the attention of Equity Shareholders / Beneficial Owners of Equity Shares ....
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Centrum Broking Ltd, as Manager to the Buyback, has submitted the Post Buyback Public Announcement for Jagsonpal Pharmaceuticals Ltd. The buyback offer, which had a Letter of Offer dated May 06, 2026, opened on May 08, 2026 and closed on May 14, 2026. The Post Buyback Public Announcement was published on May 25, 2026, within 2 working days from completion of payment consideration to eligible shareholders. The announcement was published in Financial Express (English) and Jansatta (Hindi) newspapers. The buyback was conducted under SEBI (Buy-back of Securities) Regulations, 2018 for fully paid-up equity shares of face value ₹2 each.
The completion of this buyback means the company has returned capital to shareholders who tendered shares. The market typically views completed buybacks positively as they indicate management confidence in undervaluation. Shareholders who participated received the buyback price.